Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.

The global micro-needle flu vaccine market is estimated to be valued at US$ 1322.1 Mn in 2020 and is expected to exhibit a CAGR of 6.1% during the forecast period (2020-2027).

Figure 1. Global Micro-needle Flu Vaccine Market Value (US$ Mn), 2016-2027

Micro-needle Flu Vaccine  | Coherent Market Insights

Key companies are focusing on inorganic strategies such as mergers and acquisitions to strengthen their position in the global micro-needle flu vaccine market. For instance, in June 2020, Microdermics, Inc, came into a strategic merger with Novateur Ventures, an established global life sciences advisory company to provide strategic advisory support and to lead the transaction process for commercializing novel micro-needle flu vaccine and biosensing platform.

Moreover, government regulatory bodies taking initiatives to decrease the prevalence of influenza flu in the U.S. is expected to drive growth of the micro-needle flu vaccine market. For instance, in 2019, according to the Advisory Committee on Immunization Practices, a committee in the U.S. for Centers for Disease Control and Prevention, which provides advice and guidance on effective control of diseases in the U.S., stated that every individuals of 6 month of age and older should get an influenza flu vaccine every season to decrease the incidence of flu affecting individuals in the U.S.

request-sample

Micro-needle Flu Vaccine Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 1,322.1 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.1% 2027 Value Projection: US$ 2006.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle.
  • By Vaccine Type: Trivalent Flu Vaccine, Quadrivalent Flu Vaccine.
  • By Flu Type:
    • Influenza A: H1N1, H3N2.
    • Influenza B.
Companies covered:

Sanofi S.A., GC Pharma, Debiotech S.A, 3M Company, NanoPass Technologies Limited, Corium International, Inc, Becton, Dickinson and Company, FluGen, Inc, CosMED Pharmaceuticals Co., Ltd, Microdermics and OraSure Technologies, Inc.

Growth Drivers:
  • Increasing prevalence of influenza and viral infections
  • Key players focusing on research and development of micro-needle flu vaccines
  • Key companies focusing on inorganic strategies such as mergers and acquisitions
Restraints & Challenges:
  • The external environment such as hydration of the skin could affect drug delivery
  • Repetitive injection may collapse the veins
  • The tip of the microneedle may break off and remain within the skin on removal of the patch

Global Microneedle Flu Vaccine Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in more than 45 million infected individuals worldwide, as of October 30, 2020.

The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe have impacted the financial status of major companies in micro-needle flu vaccine vaccines. The private healthcare sector is one of the sectors, which has been majorly impacted by the COVID-19 pandemic. The pandemic has negatively impacted the global micro-needle flu vaccine market in various aspects such as development, production, and supply of medicines and also affected growth of the pharmaceutical businesses of various companies across the globe due to lockdowns implemented by governments of several countries. The nationwide lockdowns have led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the raw materials and drugs for therapeutic use.

Figure 2. Global Microneedle Flu Vaccine Market Share (%), by Region, 2020

Micro-needle Flu Vaccine  | Coherent Market Insights

Among regions, In North America, Launch of new campaigns and initiatives by healthcare agencies in order to prevent the flu is expected to drive demand for influenza vaccine and development of effective delivery systems for vaccination. For instance, in October 2020, the Centers for Disease Control and Prevention (CDC) and the National Foundation for Infectious Diseases (NFID), along with other public health and medical groups collaboratively announced the launch of 2020-2021 flu vaccination season and emphasized the importance of vaccination and recommended that everyone 6 months and older should get vaccinated against flu, annually

Key Players

Major players operating in the global microneedle flu vaccine market include Sanofi S.A., GC Pharma, Debiotech S.A, 3M Company, NanoPass Technologies Limited, Corium International, Inc, Becton, Dickinson and Company, FluGen, Inc, CosMED Pharmaceuticals Co., Ltd, Microdermics and OraSure Technologies, Inc.

Drug delivery through the skin by transdermal patches has always been effective against viral infection and flu. Drug delivery through transdermal route is mainly effective due to passive diffusion of the drug and followed by drug development in transdermal delivery systems through different mechanism of action such as iontophorresis and sonophoresis. Moreover, pharmaceutical companies are focusing on development of micro-needle vaccines due to its immense utility in transdermal delivery of very large drug molecules with ionic and hydrophilic nature.

Market Dynamics

The global micro-needle flu vaccine market is expected to witness significant growth during the forecast period, as government agencies are investing more on the research and development of microneedle vaccine patches. For instance, in August 2020, Verndari, Inc received the funding of US$ 1 million from the U.S. Government Agency BARDA for accelerating the research and development of VaxiPatch, a dermal patch vaccine technology that can be used for treatment of various infectious diseases such as influenza flu.

Key features of the study:

  • This report studies the current scenario as well as the future potential for the global microneedle flu vaccine market. The market for microneedle flu vaccine is segmented on basis of product type, vaccine type, flu type and region.
  • This report provides in-depth analysis of the global microneedle flu vaccine market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020 – 2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global microneedle flu vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global microneedle flu vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the global microneedle flu vaccine market.

Detailed Segmentation:

  • Global Microneedle Flu Vaccine Market, By Product Type:
    • Solid Microneedle
    • Hollow Microneedle
    • Coated Microneedle
    • Dissolving Microneedle
  • Global Microneedle Flu Vaccine Market, By Vaccine Type:
    • Trivalent Flu Vaccine
    • Quadrivalent Flu Vaccine
  • Global Microneedle Flu Vaccine Market, By Flu Type:
    • Influenza A
      • H1N1
      • H3N1
    • Influenza B
  • Global Microneedle Flu Vaccine Market, By Region:
    • North America
      • By Product Type:
        • Solid Microneedle
        • Hollow Microneedle
        • Coated Microneedle
        • Dissolving Microneedle
      • By Vaccine Type:
        • Trivalent Flu Vaccine
        • Quadrivalent Flu Vaccine
      • By Virus Type:
        • Influenza A
          • H1N1
          • H3N1
        • Influenza B
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Solid Microneedle
        • Hollow Microneedle
        • Coated Microneedle
        • Dissolving Microneedle
      • By Vaccine Type:
        • Trivalent Flu Vaccine
        • Quadrivalent Flu Vaccine
      • By Virus Type:
        • Influenza A
          • H1N1
          • H3N1
        • Influenza B
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Solid Microneedle
        • Hollow Microneedle
        • Coated Microneedle
        • Dissolving Microneedle
      • By Vaccine Type:
        • Trivalent Flu Vaccine
        • Quadrivalent Flu Vaccine
      • By Virus Type:
        • Influenza A
          • H1N1
          • H3N1
        • Influenza B
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Solid Microneedle
        • Hollow Microneedle
        • Coated Microneedle
        • Dissolving Microneedle
      • By Vaccine Type:
        • Trivalent Flu Vaccine
        • Quadrivalent Flu Vaccine
      • By Virus Type:
        • Influenza A
          • H1N1
          • H3N1
        • Influenza B
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Solid Microneedle
        • Hollow Microneedle
        • Coated Microneedle
        • Dissolving Microneedle
      • By Vaccine Type:
        • Trivalent Flu Vaccine
        • Quadrivalent Flu Vaccine
      • By Virus Type:
        • Influenza A
          • H1N1
          • H3N1
        • Influenza B
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Solid Microneedle
        • Hollow Microneedle
        • Coated Microneedle
        • Dissolving Microneedle
      • By Vaccine Type:
        • Trivalent Flu Vaccine
        • Quadrivalent Flu Vaccine
      • By Virus Type:
        • Influenza A
          • H1N1
          • H3N1
        • Influenza B
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Vaccine Companies:
      • Sanofi S.A.*
        • Company Overview
        • Material Portfolio
        • Financial Performance
        • Key Highlights
        • Market Strategies
      • GC Pharma
    • Microneedle Companies:
      • Debiotech S.A*
        • Company Overview
        • Material Portfolio
        • Financial Performance
        • Key Highlights
        • Market Strategies
      • 3M Company
      • NanoPass Technologies Limited
      • Corium International, Inc
      • Becton, Dickinson and Company
      • FluGen, Inc.
      • CosMED Pharmaceuticals Co., Ltd.
      • Microdermics
      • OraSure Technologies, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Vaccine Type
      • Market Snapshot, By Flu Type
      • Market Snapshot, By Region
    • Market Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraint
    • Opportunity
    • Impact Analysis
    • Epidemiology
    • Pipeline Analysis – Influenza Vaccine
    • List of Marketed Microneedles
    • Developments of Microneedles
    • Key Highlights
    • PEST Analysis
    • Acquisition and Collaboration Scenario
    • Market Trends
    • Regulatory Scenario
    • Recent Advancements in Microneedle Flu Vaccine
    • Influenza Vaccination Rate
    • Demand for Influenza Vaccine – Taiwan
    • Suppliers of Influenza Vaccine
    • Brand Analysis
  4. Global Microneedle Flu Vaccine Market, Impact of COVID-19 Pandemic
    • COVID-19 Epidemiology
    • COVID-19 Impact on the Overall Healthcare Market
    • Government Initiatives to Combat Seasonal Influenza Amid COVID-19
    • Government Initiatives to Combat COVID-19
    • Demand & Supply Impact
  5. Global Microneedle Flu Vaccine Market, By Product Type , 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Solid Microneedles
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Hollow Microneedles
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Coated Microneedles
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Dissolving Microneedles
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Global Microneedle Flu Vaccine Market, By Vaccine Type , 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Trivalent Flu Vaccine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Quadrivalent Flu Vaccine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Microneedle Flu Vaccine Market, By Flu Type, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Influenza A
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
            • H1N1
            • H3N2
        • Influenza B
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Microneedle Flu Vaccine Market, By Region, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Bn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
    • Vaccine Companies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GC Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Microneedle Companies
      • Debiotech S.A
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • 3M Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NanoPass Technologies Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Corium International, Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • FluGen, Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • CosMED Pharmaceuticals Co.,Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Microdermics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • OraSure Technologies, Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 35 market data tables and 32 figures on "Microneedle Flu Vaccine Market – Global Forecast to 2027”.

Frequently Asked Questions

The global micro-needle market size is estimated to be valued at US$ 1322.1 million in 2020 and is expected to exhibit a CAGR of 6.1% between 2020 and 2027.
Key companies are focusing on strategic collaboration and research agreements, coupled with inorganic strategies such as mergers and acquisitions are the factors that are expected to drive growth of the micro-needle flu vaccine system market.
Solid microneedles segment is estimated to account for major market share in 2020, owing to key players such as 3M offer solid microneedle technology, which relies on tiny needles mounted on wearable patches to deliver vaccines.
Quadrivalent Flu vaccine segment is estimated to account for major market share in 2020, owing to growing demand for Fluzone High-Dose quadrivalent vaccine for treatment of influenza.
Influenza A segment is estimated to account for major market share in 2020, owing to rising prevalence and severity of H3N2 infection.
North America is estimated to hold largest revenue share in 2020 in the global micro-needle flu vaccine market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner